Next-gen Quell wearable pain relief device clears the FCC

Quell

NeuroMetrix has received FDA’s 510(k) clearance for an upgraded version of Quell, the company’s drug-free chronic pain relief wearable. That upgraded model will enable control of the Quell device using the Quell Relief smartphone app. This, NeuroMetrix claims, provides for a better user experience.

“This 510(k) further advances Quell technology by allowing the device to be conveniently and safely controlled via a smartphone,” Shai Gozani, M.D., Ph.D., President and CEO NeuroMetrix, said in a statement. “It is a clear example of our unwavering commitment to creating the most clinically effective and technologically innovative wearable therapeutic solution for people suffering from chronic pain. It is only fitting that we are making this announcement at CES 2016 which is the international showcase for consumer technology breakthroughs.”

In addition to allowing users to control Quell from a mobile app, the new model will also come with an extended battery life and advanced sleep tracking. It will be available in March 2016, with existing users being able to send in their previous generation devices for the free upgrade.